146 related articles for article (PubMed ID: 15679635)
1. Human IgE response to the Schistosoma haematobium 22.6 kDa antigen.
Fitzsimmons CM; Stewart TJ; Hoffmann KF; Grogan JL; Yazdanbakhsh M; Dunne DW
Parasite Immunol; 2004; 26(8-9):371-6. PubMed ID: 15679635
[TBL] [Abstract][Full Text] [Related]
2. Identification of the Schistosoma japonicum 22.6-kDa antigen as a major target of the human IgE response: similarity of IgE-binding epitopes to allergen peptides.
Santiago ML; Hafalla JC; Kurtis JD; Aligui GL; Wiest PM; Olveda RM; Olds GR; Dunne DW; Ramirez BL
Int Arch Allergy Immunol; 1998 Oct; 117(2):94-104. PubMed ID: 9784652
[TBL] [Abstract][Full Text] [Related]
3. A recombinant protein from Schistosoma mansoni useful for the detection of S. mansoni and Schistosoma haematobium antibodies.
Hancock K; Mohamed YB; Haichou X; Noh J; Dotson EM; Tsang VC
J Parasitol; 1997 Aug; 83(4):612-8. PubMed ID: 9267400
[TBL] [Abstract][Full Text] [Related]
4. Antibody responses in schistosomiasis haematobium in Somalia. Relation to age and infection intensity.
Hagi H; Huldt G; Loftenius A; Schröder H
Ann Trop Med Parasitol; 1990 Apr; 84(2):171-9. PubMed ID: 2116776
[TBL] [Abstract][Full Text] [Related]
5. Immuno-epidemiology of human Schistosoma haematobium infection: preferential IgG3 antibody responsiveness to a recombinant antigen dependent on age and parasite burden.
Mutapi F; Mduluza T; Gomez-Escobar N; Gregory WF; Fernandez C; Midzi N; Maizels RM
BMC Infect Dis; 2006 Jun; 6():96. PubMed ID: 16764709
[TBL] [Abstract][Full Text] [Related]
6. Preferential recognition by human IgE and IgG4 of a species-specific Schistosoma haematobium serine protease inhibitor.
Li Z; King CL; Ogundipe JO; Licate LS; Blanton RE
J Infect Dis; 1995 Feb; 171(2):416-22. PubMed ID: 7844379
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting human IgE and IgG responses to allergen-like Schistosoma mansoni antigens: Molecular structure and patterns of in vivo exposure.
Fitzsimmons CM; McBeath R; Joseph S; Jones FM; Walter K; Hoffmann KF; Kariuki HC; Mwatha JK; Kimani G; Kabatereine NB; Vennervald BJ; Ouma JH; Dunne DW
Int Arch Allergy Immunol; 2007; 142(1):40-50. PubMed ID: 17019080
[TBL] [Abstract][Full Text] [Related]
8. Rapidly boosted Plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils.
Wilson S; Jones FM; Fofana HK; Doucouré A; Landouré A; Kimani G; Mwatha JK; Sacko M; Vennervald BJ; Dunne DW
PLoS Negl Trop Dis; 2013; 7(3):e2149. PubMed ID: 23556029
[TBL] [Abstract][Full Text] [Related]
9. The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium.
Mutapi F; Mduluza T; Ndhlovu PD
Mem Inst Oswaldo Cruz; 2002; 97 Suppl 1():173-80. PubMed ID: 12426616
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting high and low human IgE responses to schistosome worm antigens in an area of Brazil endemic for Schistosoma mansoni and hookworm.
Webster M; Correa-Oliveira R; Gazzinelli G; Viana IR; Fraga LA; Silveira AM; Dunne DW
Am J Trop Med Hyg; 1997 Oct; 57(4):487-94. PubMed ID: 9347969
[TBL] [Abstract][Full Text] [Related]
11. The Schistosoma mansoni tegumental-allergen-like (TAL) protein family: influence of developmental expression on human IgE responses.
Fitzsimmons CM; Jones FM; Stearn A; Chalmers IW; Hoffmann KF; Wawrzyniak J; Wilson S; Kabatereine NB; Dunne DW
PLoS Negl Trop Dis; 2012; 6(4):e1593. PubMed ID: 22509417
[TBL] [Abstract][Full Text] [Related]
12. Age-related antibody profiles in Schistosoma haematobium infections in a rural community in Zimbabwe.
Ndhlovu P; Cadman H; Vennervald BJ; Christensen NO; Chidimu M; Chandiwana SK
Parasite Immunol; 1996 Apr; 18(4):181-91. PubMed ID: 9223173
[TBL] [Abstract][Full Text] [Related]
13. Human IgE, IgG subclass, and IgM responses to worm and egg antigens in schistosomiasis haematobium: a 12-month study of reinfection in Cameroonian children.
Naus CW; van Dam GJ; Kremsner PG; Krijger FW; Deelder AM
Clin Infect Dis; 1998 May; 26(5):1142-7. PubMed ID: 9597243
[TBL] [Abstract][Full Text] [Related]
14. Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults.
Grogan JL; Kremsner PG; van Dam GJ; Metzger W; Mordmüller B; Deelder AM; Yazdanbakhsh M
J Infect Dis; 1996 May; 173(5):1242-7. PubMed ID: 8627078
[TBL] [Abstract][Full Text] [Related]
15. Human Schistosoma haematobium antifecundity immunity is dependent on transmission intensity and associated with immunoglobulin G1 to worm-derived antigens.
Wilson S; Jones FM; van Dam GJ; Corstjens PL; Riveau G; Fitzsimmons CM; Sacko M; Vennervald BJ; Dunne DW
J Infect Dis; 2014 Dec; 210(12):2009-16. PubMed ID: 25001462
[TBL] [Abstract][Full Text] [Related]
16. [Determination of parasite-specific antibodies during human schistosomiasis--diagnostic relevance].
Sauer H; Leykun J; Schubert S
Angew Parasitol; 1992 Aug; 33(3):151-9. PubMed ID: 1416221
[TBL] [Abstract][Full Text] [Related]
17. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.
Dunne DW; Butterworth AE; Fulford AJ; Kariuki HC; Langley JG; Ouma JH; Capron A; Pierce RJ; Sturrock RF
Eur J Immunol; 1992 Jun; 22(6):1483-94. PubMed ID: 1601036
[TBL] [Abstract][Full Text] [Related]
18. Use of human infection and vaccine-protected baboon sera for the characterisation of cloned Schistosoma haematobium antigen genes.
Renganathan EA; Schaefer KU; Bickle QD
Trop Med Parasitol; 1993 Sep; 44(3):187-91. PubMed ID: 8256094
[TBL] [Abstract][Full Text] [Related]
19. Adult schistosome cDNA libraries as a source of antigens for the study of experimental and human schistosomiasis.
Knight M; Simpson AJ; Bickle Q; Hagan P; Moloney A; Wilkins A; Smithers SR
Mol Biochem Parasitol; 1986 Feb; 18(2):235-53. PubMed ID: 2938004
[TBL] [Abstract][Full Text] [Related]
20. Prospective, observational study to assess the performance of CAA measurement as a diagnostic tool for the detection of Schistosoma haematobium infections in pregnant women and their child in Lambaréné, Gabon: study protocol of the freeBILy clinical trial in Gabon.
Honkpehedji YJ; Adegnika AA; Dejon-Agobe JC; Zinsou JF; Mba RB; Gerstenberg J; Rakotozandrindrainy R; Rakotoarivelo RA; Rasamoelina T; Sicuri E; Schwarz NG; Corstjens PLAM; Hoekstra PT; van Dam GJ; Kreidenweiss A;
BMC Infect Dis; 2020 Sep; 20(1):718. PubMed ID: 32993559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
